| Company Name: |
Jinan Trio PharmaTech Co., Ltd.
|
| Tel: |
+86 (531) 88811783 |
| Email: |
sales@trio-pharmatech.com (International market) |
| Products Intro: |
CAS:835621-08-4
Purity:99% Package:5Mg, 10Mg, 20Mg, 50Mg
|
| Company Name: |
SYN|thesis med chem P/L
|
| Tel: |
+86-021-50720296 |
| Email: |
service@synkinase.com |
| Products Intro: |
Product Name:Regorafenib
CAS:835621-08-4
Purity:>98% Package:1Mg;5Mg;10Mg;50Mg;100Mg
|
- Regorafenib
-
- $0.00 / 1g
-
2024-03-12
- CAS:835621-08-4
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 1kg
|
| | Regorafenib Basic information |
| | Regorafenib Chemical Properties |
| | Regorafenib Usage And Synthesis |
| Uses | BAY 73-4506 (Regorafenib) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. | | Definition | ChEBI: Regorafenib is a pyridinecarboxamide obtained by condensation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]pyridine-2-carboxylic acid with methylamine. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It is an aromatic ether, a pyridinecarboxamide, a member of monochlorobenzenes, a member of (trifluoromethyl)benzenes, a member of monofluorobenzenes and a member of phenylureas. |
| | Regorafenib Preparation Products And Raw materials |
|